Question 1

What are the potential side effects of IBI322?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1a Study Evaluating the Safety, Tolerability, and Efficacy of IBI322 in Subjects With Advanced Cancers clinical trial (NCT04338659). Contact the study team or your healthcare provider for specific answers.

Question 2

How does IBI322 compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1a Study Evaluating the Safety, Tolerability, and Efficacy of IBI322 in Subjects With Advanced Cancers clinical trial (NCT04338659). Contact the study team or your healthcare provider for specific answers.

Question 3

What is the expected duration of the treatment and how often will I need to come in for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1a Study Evaluating the Safety, Tolerability, and Efficacy of IBI322 in Subjects With Advanced Cancers clinical trial (NCT04338659). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or procedures I will need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1a Study Evaluating the Safety, Tolerability, and Efficacy of IBI322 in Subjects With Advanced Cancers clinical trial (NCT04338659). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or if my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1a Study Evaluating the Safety, Tolerability, and Efficacy of IBI322 in Subjects With Advanced Cancers clinical trial (NCT04338659). Contact the study team or your healthcare provider for specific answers.

Question 6

Can I continue my current medications while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1a Study Evaluating the Safety, Tolerability, and Efficacy of IBI322 in Subjects With Advanced Cancers clinical trial (NCT04338659). Contact the study team or your healthcare provider for specific answers.

What this study is about